Results 111 to 120 of about 117,941 (168)

Advances in Antibacterial Therapy

Transplantation Proceedings, 2011
Bacterial resistance is still a major concern in antibiotic therapy, especially for immunocompromised and transplantation patients. New therapeutic options are, therefore, needed to overcome the onset of antibiotic resistance. This article reviews the potential role of some antibiotics recently marketed or in clinical development, with a focus on their
openaire   +2 more sources

Neurotoxicity of Antibacterial Therapy

Southern Medical Journal, 1994
The increasing variety of drugs available for the treatment of bacterial infections has simultaneously increased the potential for toxicity. Neurologic toxicity of antibacterial therapy is generally underestimated in scope and severity; it may be classified as central, peripheral, or due to drug-interactions, several of which are potentially life ...
openaire   +3 more sources

Nanomaterials in Antibacterial Photodynamic Therapy and Antibacterial Sonodynamic Therapy

Advanced Functional Materials
AbstractAntibacterial photodynamic therapy (aPDT) and antibacterial sonodynamic therapy (aSDT) utilize sensitizers (photosensitizers/sonosensitizers) to produce reactive oxygen species (ROS) for antibacterial treatment under the stimulation of light/ultrasound, which have the characteristics of broad‐spectrum antibacterial properties, low drug ...
Chaonan He, Peipei Feng, Mingming Hao, Yun Tang, Xiang Wu, Wenguo Cui, Jingyun Ma, Chunhai Ke   +7 more
openaire   +1 more source

Antibacterial Therapy of Neurosyphilis

CNS Drugs, 2002
Neurosyphilis is caused by the spirochete Treponema pallidum. These organisms divide slowly, requiring long exposure to antibacterials for treatment success. In order for an antibacterial to be effective in the therapy of neurosyphilis, it must achieve treponemicidal concentrations in the CSF, have a long half-life and be given in a treatment regimen ...
Latisha, Ali, Karen L, Roos
openaire   +2 more sources

The antibacterial therapy of tuberculosis

Tubercle, 1958
Summary Drugs at present available for the treatment of tuberculosis are sufficiently powerful to permit clinical recovery with bacterial negativity and a low relapse rate in almost all patients with active tuberculosis. Some aspects of their use are discussed, with emphasis on possible reasons for the occasional therapeutic failure.
openaire   +2 more sources

Rational perioperative antibacterial therapy

In Practice, 1995
ANTIBACTERIAL agents do not cure bacterial infections; rather, they allow the natural defence mechanisms of the body, both immune‐mediated and innate, to eliminate infection. They work most effectively when the causes of infection are controlled. In rational antibacterial therapy the use of antibacterial agents is restricted to situations where they ...
openaire   +1 more source

[Antibacterial combination therapy].

Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1977
Reasons for the use of antibacterial combinations are synergistic effects and delayed development of bacterial resistance. On the basis of numerous experiments in vitro the opinion is supported that a clinically useful synergism depends on the addition of an aminoglycoside, the second compound being either one of the penicillins or cephalosporins, or a
openaire   +1 more source

Magnetic resonance linear accelerator technology and adaptive radiation therapy: An overview for clinicians

Ca-A Cancer Journal for Clinicians, 2022
William A Hal, X Allen Li, Daniel A Low
exaly  

Antibacterial therapy

Journal of the American Academy of Dermatology, 1987
openaire   +2 more sources

Antibacterial therapy continued

Journal of the American Academy of Dermatology, 1987
openaire   +2 more sources